Clinical haematological biomarkers: Derived neutrophil-to-lymphocyte ratio (dNLR), platelet-to-lymphocyte ratio (PLR), and prognostic nutritional index (PNI) and their relationship to survival outcomes in non small cell lung cancer (NSCLC) treated with immunotherapy: A multicenter review.

Colum Dennehy,Eileen McMahon,Derek G. Power,Seamus O’Reilly,Dearbhaile Catherine Collins,Deirdre O'Mahony,Anne M. Horgan,Miriam O'Connor,Emmet Jordan,Paula Calvert,Richard Martin Bambury

Clinical haematological biomarkers: Derived neutrophil-to-lymphocyte ratio (dNLR), platelet-to-lymphocyte ratio (PLR), and prognostic nutritional index (PNI) and their relationship to survival outcomes in non small cell lung cancer (NSCLC) treated with immunotherapy: A multicenter review.

2019

Colum Dennehy
Eileen McMahon
Derek G. Power
Seamus O’Reilly
Dearbhaile Catherine Collins
Deirdre O'Mahony
Anne M. Horgan
Miriam O'Connor
Emmet Jordan
Paula Calvert
Richard Martin Bambury

e20704Background: Efficient use of immunotherapy in non-small-cell lung cancer (NSCLC) has been limited by the lack of a definitive predictive biomarker. Recently considerable efforts have been inv...

Keywords:

Neutrophil to lymphocyte ratio
Immunotherapy
non-small cell lung cancer (NSCLC)
Platelet
Lung cancer
Lymphocyte
Biomarker (medicine)
Oncology
Pathology
Prognostic Nutritional Index (PNI)
Medicine
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations